Comment on “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”

  • Rudolf Hoermann, John E. M. Midgley, Rolf Larisch, Johannes W. Dietrich
  • Clinical Pharmacokinetics, March 2020, Springer Science + Business Media
  • DOI: 10.1007/s40262-020-00887-x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s40262-020-00887-x

The following have contributed to this page: Professor Rudolf Hoermann and PD Dr. med. Johannes W Dietrich